5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Aorto-Right Ventricular Fistula Post-Transcatheter Aortic Valve Replacement: Multimodality Imaging of Successful Percutaneous Closure

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Graphical abstract

          Highlights

          • Aorto-right ventricular fistula is a rare diagnosis and is on the spectrum of aortic periannular rupture.

          • Multimodality imaging is crucial in identifying aortic periannular rupture, defining its course, and for preprocedural planning.

          • We describe a case of aorto-right ventricular fistula, which was successfully treated using an Amplazter vascular plug intravenous device (St. Jude Medical) and is to our knowledge the first reported case of using a plugging device for this type of disorder.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement.

          Patient selection for transcatheter aortic valve replacement (TAVR) should include assessment of the risks of TAVR compared with surgical aortic valve replacement (SAVR). Existing SAVR risk models accurately predict the risks for the population undergoing SAVR, but comparable models to predict risk for patients undergoing TAVR are currently not available and should be derived from a population that underwent TAVR.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention.

            Annular rupture is an umbrella term covering different procedural-related injuries that may occur in the region of the aortic root and the left ventricular outflow tract during transcatheter aortic valve replacement. According to the anatomical location of the injury, there are 4 main types: supra-annular, intra-annular, subannular, and combined rupture. Annular rupture is a rare, unpredictable, and potentially fatal complication. It can be treated successfully if it is immediately recognized and adequately managed. The type of therapy depends on the location of the annular rupture and the nature of the clinical manifestations. Treatment approaches include conventional cardiac procedure, isolated pericardial drainage, and conservative therapy. This summary describes theoretical and practical considerations of the etiology, pathophysiology, classification, natural history, diagnostic and treatment strategies, and prevention approaches of annular rupture.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure.

              Transcatheter aortic valve replacement (TAVR) has become a safe and effective therapy for patients with severe aortic stenosis (AS). In recent trials, the hemodynamic performance and clinical outcomes of the latest generation of TAVR devices demonstrated at least parity with surgical outcomes in patients of similar risk. Many initial obstacles with TAVR have largely been overcome, including frequent access site complications and concerns about strokes and paravalvular leaks. Using a multidisciplinary heart team approach, patient selection, procedural planning, and device implantation have been refined and optimized such that clinical outcomes are generally predictable and reproducible. Future research will focus on the durability of TAVR devices, further enhancements in clinical outcomes, and adjunctive therapies. On the basis of initial results from ongoing clinical trials, the indication for TAVR will likely expand to lower-risk patients. This review provides an overview of recent progress in this field, and highlights future opportunities and directions.
                Bookmark

                Author and article information

                Journal
                CASE (Phila)
                CASE (Phila)
                CASE : Cardiovascular Imaging Case Reports
                Elsevier
                2468-6441
                24 April 2017
                April 2017
                24 April 2017
                : 1
                : 2
                : 70-74
                Affiliations
                [a ]Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York, New York
                [b ]Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, New York
                [c ]Department of Radiology, New York University Langone Medical Center, New York, New York
                Article
                S2468-6441(16)30029-9
                10.1016/j.case.2017.02.002
                6034486
                30062248
                66e2b076-376b-4f53-abc0-e59d9fd08b05
                Copyright 2017 by the American Society of Echocardiography. Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Percutaneous Peril

                transthoracic echocardiography,3d transesophageal echocardiography,multidetector computed tomography,percutaneous closure,tavr

                Comments

                Comment on this article